Nano Dimension (NNDM) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
31 Mar, 2026Executive summary
Streamlined operations and reduced cash burn in the second half of 2025, focusing on high-value industry segments and advanced technologies.
Achieved full-year 2025 revenue of $102.4 million, up 77.3% year-over-year, driven by acquisitions and organic growth.
Exceeded fourth quarter financial guidance and initiated share repurchases, buying over 14.4 million shares in late 2025.
Completed two major acquisitions (Desktop Metal and Markforged), with Desktop Metal deconsolidated after Chapter 11 and Markforged integrated into results.
Initiated a strategic alternatives review, with announcements expected in Q2 2026 to clarify the path to profitability and shareholder value.
Financial highlights
Q4 2025 revenue was $35.3M, up 142% year-over-year, mainly due to Markforged acquisition; standalone revenue flat at $14.6M.
Full-year 2025 revenue was $102.4M, up 77% year-over-year; adjusted EBITDA loss was $53.2M, improved from $63.6M in 2024.
Q4 operating expenses were $27.3M, up 13% year-over-year due to Markforged, but standalone expenses fell 42% year-over-year.
Q4 adjusted EBITDA loss was $9.8M, improving from $18.9M loss in Q4 2024 and $16.6M in Q3 2025.
Cash, equivalents, and marketable securities were $459.6M at year-end, down from $515.5M in Q3, reflecting share repurchases and market value changes.
Outlook and guidance
2026 revenue guidance: $130M–$140M, over 30% growth at midpoint, driven by continued momentum in key segments.
Non-GAAP gross margin expected at 46%–48%; operating expenses $106M–$111M; adjusted EBITDA loss $40M–$50M, showing improvement.
Revenue expected to ramp in the second half of 2026, with Q1 typically the lightest and Q4 the strongest.
Latest events from Nano Dimension
- $890M merger forms a Nasdaq-listed AI diagnostics leader targeting the $90–94B U.S. market.NNDM
M&A announcement16 Jun 2026 - Nano and Infinite plan a merger to create an AI-powered health diagnostics company, pending approvals.NNDM
Proxy filing15 Jun 2026 - Board supports declassification but opposes director removal and other governance changes.NNDM
Proxy filing11 Jun 2026 - Shareholders will vote on strategic direction, board structure, and director changes amid a proxy contest.NNDM
Proxy filing5 Jun 2026 - Strategic plan advances with cost cuts, asset sales, and a pivotal shareholder vote ahead.NNDM
Proxy filing5 Jun 2026 - Board opposes activist director replacements, prioritizing strategic review and shareholder value.NNDM
Proxy filing26 May 2026 - Q1 2026 revenue surged 106% year-over-year, but net loss deepened amid restructuring and impairment.NNDM
Q1 20267 May 2026 - A $183M all-cash merger forms a global additive manufacturing leader with $30M+ synergies.NNDM
M&A Announcement3 Feb 2026 - Gross margin hit 50% (adjusted) and net cash burn fell 75% year-over-year.NNDM
Q1 202431 Jan 2026